PhAMA advocates for industry-related issues that will directly or indirectly impact the healthcare ecosystem, and serves as a intermediary between the industry and government. The committees involved in this pillar of focus are:


Work with the government in providing technical input, Real-World Data/Evidence, global expertise, data-driven analytics to ensure an enabling environment for the industry and healthcare system.

Access and procurement

Support industry growth through the National Formulary Listing aims to and efficient procurement processes to increase market access, and enhance Patient Access Schemes (PASc) to widen access to innovative medicines.

Intellectual property (IP) and innovations

Stewardship over patent protection and intellectual property rights, as well as working with relevant authorities on fighting counterfeit medicines that may threaten life or limb.